Stem Cell Company t2cure Appoints Dr Petra Rueck and Susanne Knigge as Co-CEOs
t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based therapies, announced today that it has appointed Dr. Petra Rueck and Mrs. Susanne Knigge to Co-CEO’s, effective January 1, 2010.
[Read the full article here]Related News:
Stem Cell Therapy Appoints New Board Member
NeoStem Named ‘Best Stem Cell Company’ in The New Economy’s 2010 Biotech Awards
Bio-Matrix Scientific Group, Inc. Outlines Strategy for Growth in 2010 With Focus on Developing Stem Cell Related …